No Half Measures How Medical Affairs Can Assess and Maximize Value Education and knowledge transfer must be prioritized for pharma to see sizable improvement in medical affairs

No Half Measures How Medical Affairs Can Assess and Maximize Value Education and knowledge transfer must be prioritized for pharma to see sizable improvement in medical affairs

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmaceutical executive 2022-04, Vol.42 (4), p.40
Hauptverfasser: Bubach, Patrick, Murama, Jean-Jacques, Budden, Ailsa, Sigl, Lisa
Format: Magazinearticle
Sprache:eng
Schlagworte:
Pharmaceutical industry
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 4
container_start_page 40
container_title Pharmaceutical executive
container_volume 42
creator Bubach, Patrick
Murama, Jean-Jacques
Budden, Ailsa
Sigl, Lisa
description
format Magazinearticle
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_businessinsightsgauss_A701744755</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A701744755</galeid><sourcerecordid>A701744755</sourcerecordid><originalsourceid>FETCH-gale_businessinsightsgauss_A7017447553</originalsourceid><addsrcrecordid>eNqVjktOw0AQRL0AifC5Qx2ASAOxMSytKMibsEJso3bcdhrmY03PEJRTcUQiyAVYlUr1Snpnxczc10_zh6o2F8Wl6rsxpiyrx1nx_RLQkh2wZtIcWdGG_bH0siWLZhhIomJJHo0qq4J8jzV9iZMD441sZqz6vKUkwf-OHz7sLfcjI0XyOnCEy5rQMaYoIUo6PnsMIWLaUXSEFKDMUDlQZxniphg-2bFPEA93cqE_l-vifCCrfHPKq-L2efW6bOcjWd50WcUfNcWrjLukI2XVTVObu7os66pa_BP_AU1raPM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>magazinearticle</recordtype></control><display><type>magazinearticle</type><title>No Half Measures How Medical Affairs Can Assess and Maximize Value Education and knowledge transfer must be prioritized for pharma to see sizable improvement in medical affairs</title><source>Business Source Complete</source><creator>Bubach, Patrick ; Murama, Jean-Jacques ; Budden, Ailsa ; Sigl, Lisa</creator><creatorcontrib>Bubach, Patrick ; Murama, Jean-Jacques ; Budden, Ailsa ; Sigl, Lisa</creatorcontrib><identifier>ISSN: 0279-6570</identifier><language>eng</language><publisher>Intellisphere, LLC</publisher><subject>Pharmaceutical industry</subject><ispartof>Pharmaceutical executive, 2022-04, Vol.42 (4), p.40</ispartof><rights>COPYRIGHT 2022 Intellisphere, LLC</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,780</link.rule.ids></links><search><creatorcontrib>Bubach, Patrick</creatorcontrib><creatorcontrib>Murama, Jean-Jacques</creatorcontrib><creatorcontrib>Budden, Ailsa</creatorcontrib><creatorcontrib>Sigl, Lisa</creatorcontrib><title>No Half Measures How Medical Affairs Can Assess and Maximize Value Education and knowledge transfer must be prioritized for pharma to see sizable improvement in medical affairs</title><title>Pharmaceutical executive</title><subject>Pharmaceutical industry</subject><issn>0279-6570</issn><fulltext>true</fulltext><rsrctype>magazinearticle</rsrctype><creationdate>2022</creationdate><recordtype>magazinearticle</recordtype><sourceid>N95</sourceid><recordid>eNqVjktOw0AQRL0AifC5Qx2ASAOxMSytKMibsEJso3bcdhrmY03PEJRTcUQiyAVYlUr1Snpnxczc10_zh6o2F8Wl6rsxpiyrx1nx_RLQkh2wZtIcWdGG_bH0siWLZhhIomJJHo0qq4J8jzV9iZMD441sZqz6vKUkwf-OHz7sLfcjI0XyOnCEy5rQMaYoIUo6PnsMIWLaUXSEFKDMUDlQZxniphg-2bFPEA93cqE_l-vifCCrfHPKq-L2efW6bOcjWd50WcUfNcWrjLukI2XVTVObu7os66pa_BP_AU1raPM</recordid><startdate>20220401</startdate><enddate>20220401</enddate><creator>Bubach, Patrick</creator><creator>Murama, Jean-Jacques</creator><creator>Budden, Ailsa</creator><creator>Sigl, Lisa</creator><general>Intellisphere, LLC</general><scope>N95</scope><scope>XI7</scope></search><sort><creationdate>20220401</creationdate><title>No Half Measures How Medical Affairs Can Assess and Maximize Value Education and knowledge transfer must be prioritized for pharma to see sizable improvement in medical affairs</title><author>Bubach, Patrick ; Murama, Jean-Jacques ; Budden, Ailsa ; Sigl, Lisa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-gale_businessinsightsgauss_A7017447553</frbrgroupid><rsrctype>magazinearticle</rsrctype><prefilter>magazinearticle</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Pharmaceutical industry</topic><toplevel>online_resources</toplevel><creatorcontrib>Bubach, Patrick</creatorcontrib><creatorcontrib>Murama, Jean-Jacques</creatorcontrib><creatorcontrib>Budden, Ailsa</creatorcontrib><creatorcontrib>Sigl, Lisa</creatorcontrib><collection>Gale Business: Insights</collection><collection>Business Insights: Essentials</collection><jtitle>Pharmaceutical executive</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bubach, Patrick</au><au>Murama, Jean-Jacques</au><au>Budden, Ailsa</au><au>Sigl, Lisa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>No Half Measures How Medical Affairs Can Assess and Maximize Value Education and knowledge transfer must be prioritized for pharma to see sizable improvement in medical affairs</atitle><jtitle>Pharmaceutical executive</jtitle><date>2022-04-01</date><risdate>2022</risdate><volume>42</volume><issue>4</issue><spage>40</spage><pages>40-</pages><issn>0279-6570</issn><pub>Intellisphere, LLC</pub></addata></record>
fulltext fulltext
identifier ISSN: 0279-6570
ispartof Pharmaceutical executive, 2022-04, Vol.42 (4), p.40
issn 0279-6570
language eng
recordid cdi_gale_businessinsightsgauss_A701744755
source Business Source Complete
subjects Pharmaceutical industry
title No Half Measures How Medical Affairs Can Assess and Maximize Value Education and knowledge transfer must be prioritized for pharma to see sizable improvement in medical affairs
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T05%3A45%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=No%20Half%20Measures%20How%20Medical%20Affairs%20Can%20Assess%20and%20Maximize%20Value%20Education%20and%20knowledge%20transfer%20must%20be%20prioritized%20for%20pharma%20to%20see%20sizable%20improvement%20in%20medical%20affairs&rft.jtitle=Pharmaceutical%20executive&rft.au=Bubach,%20Patrick&rft.date=2022-04-01&rft.volume=42&rft.issue=4&rft.spage=40&rft.pages=40-&rft.issn=0279-6570&rft_id=info:doi/&rft_dat=%3Cgale%3EA701744755%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A701744755&rfr_iscdi=true